BioSeek Press Releases 2010

Contacts

Media

Shannon Richey
Director of Marketing
313.263.0960 shannon.richey@asterand.com

Scientific

Ellen Berg, Ph.D.
Chief Scientific Officer
BioSeek, Inc.
650.888.0902
ellen.berg@asterand.com

Business Development

Ivan Plavec, Ph.D.
Vice President Business Development
BioSeek, Inc.
650.416.7629
ivan.plavec@asterand.com

Press Releases

2012 | 2011 | 2009 | 2008 | 2007 | 2006 and prior

2010
Dec. 9	Asterand To Settle Final Payment For Bioseek Acquisition With Cash
Nov. 3	Interim Management Statement
Sept. 23	Asterand's Subsidiary BioSeek Signs Agreement with Cellzome
Sept. 22	Dalia Cohen Ph.D. Joins Asterand as Chief Scientific Officer
August 26	Asterand Releases Interim Report
August 16	Notification of Interim Results
June 14	Asterand Signs Agreement with Amylin Pharmaceuticals
June 9	Annual General Meeting Statement
June 9	View Annual General Meeting Presentation
June 7	PA Extends Asterand's Role in ToxCast^TM Program
May 13	Interim Management Statement
May 10	Asterand Board Change
May 4	Asterand Signs Agreement with Eisai Co., Ltd
March 23	Asterand's Subsidiary Bioseek and Ono Initiate New Multi-Year Drug Discovery Collaboration
March 3	Notification of Preliminary Results
February 18	Asterand Completes Acquisition of BioSeek
January	Chemical Target and Pathway Toxicity Mechanisms Defined In Primary Human Cell Systems